“Profile of patients with rheumatic diseases undergoing treatment with anti-TNF agents in the Brazilian Public Health System (SUS), Belo Horizonte - MG”, Braz. J. Pharm. Sci., vol. 51, no. 3, pp. 709–719, Sep. 2015, doi: 10.1590/S1984-82502015000300023.